Production, purification and titration of a lentivirus-based vector for gene delivery purposes

被引:52
|
作者
Nasri, Masoud [1 ]
Karimi, Ali [2 ]
Farsani, Mehdi Allahbakhshian [3 ]
机构
[1] Tarbiat Modares Univ, Med Biotechnol Dept, Fac Med Sci, Tehran, Iran
[2] Shahre Kord Univ Med Sci, Med Plant Res Ctr, Shahrekord, Iran
[3] Shahid Beheshti Univ Med Sci, Fac Appl Med, Dept Hematol & Blood Banking, Tehran, Iran
关键词
Lentivirus-based vector; Transfection; Transduction; HIGH-TITER; NONDIVIDING CELLS; TRANSDUCTION; CYTOTOXICITY; GLYCOPROTEIN; PROTEIN;
D O I
10.1007/s10616-013-9652-5
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Viral vectors are valuable tools to deliver genetic materials into cells. Vectors derived from human immunodeficiency virus type 1 are being widely used for gene delivery, mainly because they are able to transduce both dividing and non-dividing cells which leads to stable and long term gene expression. In addition, these types of vectors are safe, with low toxicity, high stability and cell type specificity. Therefore, this work was aimed to produce lentivirus-based vector using a three-plasmid system. To produce this system, the eGFP marker gene was cloned into the plasmid pWPXLd. Subsequently, this vector plasmid, along with packaging plasmids, psPAX2 and envelope plasmid, pMD2.G, was co-transfected into packaging cell line (293T) using calcium phosphate method. 48 h post transfection, the constructed viral vector was harvested, purified and concentrated and stored at -80 A degrees C for next experiments. The titration of the vector was carried out, using ELISA, flowcytometry, and fluorescent microscopy. Finally, transduction of HEK-293T, CHO, HepG2, MCF-7, MEFs and Jurkat cell lines was carried out with indicated cell numbers and multiplicities of infections of the vector in the presence of polybrene. Using this system, high titer lentivirus at titers of up to 2 x 10(8) transducing units/ml (TU/ml) was successfully generated and its transduction efficacy was improved by seven to over 20-fold in various cell types. We demonstrate the applicability of this vector for the efficient transduction of dividing and non-dividing cells, including HEK-293T, CHO, HepG2, MCF-7, MEFs and Jurkat cell line. Transduction efficiency yielded titers of (6.3 +/- A 1.2) 10(5) TU/ml. Furthermore, lentivirus transferred transgene was expressed at high level in the target cells and expression was followed until 90 days after transduction. Thus, the vector generated in this work, might be able to deliver the transgene into a wide range of mammalian cells.
引用
收藏
页码:1031 / 1038
页数:8
相关论文
共 50 条
  • [11] Construction of recombinant lentivirus vector for tumor vasoinhibitory peptide alphastatin gene delivery
    Guo, S. W.
    Che, H. M.
    Li, W. Z.
    MOLECULAR MEDICINE REPORTS, 2010, 3 (06) : 923 - 928
  • [12] Third generation lentivirus as an efficient vector for therapeutic gene delivery to vascular cells
    Dishart, KL
    Denby, L
    George, SJ
    Dominiczak, AF
    Newby, AC
    Harding, T
    Baker, AH
    HEART, 2003, 89 : A15 - A15
  • [13] Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery
    Zufferey, R
    Dull, T
    Mandel, RJ
    Bukovsky, A
    Quiroz, D
    Naldini, L
    Trono, D
    JOURNAL OF VIROLOGY, 1998, 72 (12) : 9873 - 9880
  • [14] Lentivirus vector purification using anion exchange HPLC leads to improved gene transfer
    Yamada, K
    McCarty, DM
    Madden, VJ
    Walsh, CE
    BIOTECHNIQUES, 2003, 34 (05) : 1074 - +
  • [15] Long-term transgene expression by administration of a lentivirus-based vector to the fetal circulation of immuno-competent mice
    S N Waddington
    K A Mitrophanous
    F M Ellard
    S M K Buckley
    M Nivsarkar
    L Lawrence
    H T Cook
    F Al-Allaf
    B Bigger
    S M Kingsman
    C Coutelle
    M Themis
    Gene Therapy, 2003, 10 : 1234 - 1240
  • [16] Long-term transgene expression by administration of a lentivirus-based vector to the fetal circulation of immuno-competent mice
    Waddington, SN
    Mitrophanous, KA
    Ellard, FM
    Buckley, SMK
    Nivsarkar, M
    Lawrence, L
    Cook, HT
    Al-Allaf, F
    Bigger, B
    Kingsman, SM
    Coutelle, C
    Themis, M
    GENE THERAPY, 2003, 10 (15) : 1234 - 1240
  • [17] Development of a novel lentivirus-based suicide gene therapy approach using modified human thymidylate monophosphate kinase
    Sato, Takeya
    Neshadim, Anton
    Rasaiah, Vanessa
    Konrad, Manfred
    Lavie, Arnon
    Medin, Jeffrey A.
    JOURNAL OF GENE MEDICINE, 2006, 8 (03): : 399 - 399
  • [18] In Vivo Gene Delivery to the Striatum Using a Novel Entry-Targeted Lentivirus: An Entry Restricted Lentivirus Vector for Neurodegenerative Diseases
    Heldt, Scott A.
    Cox, John V.
    Krueger, Robin L.
    Albritton, Lorraine M.
    MOLECULAR THERAPY, 2012, 20 : S3 - S3
  • [19] Lentivirus-Based Virus-Like Particles Mediate Delivery of Caspase 8 into Breast Cancer Cells and Inhibit Tumor Growth
    Ao, Zhujun
    Chen, Wei
    Tan, Jun
    Cheng, Yuling
    Xu, Yanlan
    Wang, Lijun
    Yao, Xiaojian
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2019, 34 (01) : 33 - 41
  • [20] PRODUCTION OF SIV.F/HN: A NEW LENTIVIRUS VECTOR FOR CF GENE THERAPY
    Hyde, S. C.
    Alton, E.
    Boyd, A.
    Davies, J. C.
    Davies, L. A.
    Gill, D. R.
    Griesenbach, U.
    Hasegawa, M.
    Inoue, M.
    Pringle, I. A.
    Sumner-Jones, S. G.
    PEDIATRIC PULMONOLOGY, 2015, 50 : 291 - 291